-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

59th Annual Meeting and Exposition (December 9-12, 2017)

Thursday, December 7, 2017

3:00 PM-7:00 PM


Registration  
Events

Friday, December 8, 2017

7:00 AM-11:00 AM

7:00 AM-6:00 PM


Registration  
Events

12:00 PM-1:15 PM

Trainee Day

12:00 PM-5:00 PM


Training Program Directors’ Workshop  
Special-Interest Sessions

12:30 PM-4:30 PM


Test Driving CARs: Optimizing Outcomes  
Friday Satellite Symposia

1:00 PM-1:05 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Opening Remarks  
Friday Scientific Workshops

Friday Scientific Workshop on Hemoglobin Concentrations for Defining Anemia in Individuals and Populations


Opening Remarks  
Friday Scientific Workshops

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies


Opening Remarks  
Friday Scientific Workshops

Friday Scientific Workshop on Myeloid Development


Opening Remarks  
Friday Scientific Workshops

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Opening Remarks  
Friday Scientific Workshops

1:00 PM-1:10 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies


Opening Remarks  
Friday Scientific Workshops

1:05 PM-1:50 PM

Friday Scientific Workshop on Myeloid Development


Stem Cells  
Friday Scientific Workshops

1:05 PM-2:05 PM

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


New Immune Monitoring Methods  
Friday Scientific Workshops

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Stem Cells and Aging  
Friday Scientific Workshops

1:05 PM-2:25 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

1:05 PM-2:55 PM

Friday Scientific Workshop on Hemoglobin Concentrations for Defining Anemia in Individuals and Populations


Hemoglobin Thresholds and Population Health  
Friday Scientific Workshops

1:10 PM-1:55 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies


Identification of Germline Syndromes  
Friday Scientific Workshops

1:30 PM-2:30 PM

Trainee Day

Trainee Day

Trainee Day

1:50 PM-2:35 PM

Friday Scientific Workshop on Myeloid Development


Signaling and Developmental Hematopoiesis  
Friday Scientific Workshops

1:55 PM-2:40 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies


Novel Aspects of Known Predisposition Syndrome  
Friday Scientific Workshops

2:05 PM-2:20 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Panel Discussion/Questions  
Friday Scientific Workshops

2:05 PM-2:35 PM

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Panel Discussion  
Friday Scientific Workshops

2:20 PM-3:20 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Aging, Inflammation and Immune Function  
Friday Scientific Workshops

2:25 PM-2:35 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

2:35 PM-3:25 PM

Friday Scientific Workshop on Myeloid Development


New Investigators  
Friday Scientific Workshops

2:35 PM-3:35 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Novel Targets and Delivery Systems  
Friday Scientific Workshops

2:40 PM-3:25 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies


Emerging New Syndromes  
Friday Scientific Workshops

2:45 PM-3:45 PM

Trainee Day

Trainee Day

Trainee Day

3:10 PM-4:30 PM

Friday Scientific Workshop on Hemoglobin Concentrations for Defining Anemia in Individuals and Populations


Hemoglobin Thresholds and Clinical Medicine  
Friday Scientific Workshops

3:20 PM-3:35 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Panel Discussion/Questions  
Friday Scientific Workshops

3:25 PM-3:35 PM

Friday Scientific Workshop on Myeloid Development


NHLBI Presentation  
Friday Scientific Workshops

3:35 PM-3:45 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

Friday Scientific Workshop on Myeloid Development


NIDDK Presentation  
Friday Scientific Workshops

3:35 PM-4:05 PM

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Panel Discussion  
Friday Scientific Workshops

3:40 PM-4:25 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies

3:45 PM-5:05 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

3:50 PM-4:35 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Thrombosis and Aging  
Friday Scientific Workshops

4:00 PM-5:00 PM

Trainee Day

4:05 PM-5:05 PM

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Bispecific Antibodies and CAR T cells  
Friday Scientific Workshops

4:15 PM-5:00 PM

Friday Scientific Workshop on Myeloid Development


Transcription Factors/Epigenetics  
Friday Scientific Workshops

4:25 PM-5:10 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies


Reporting of Families and Variant Interpretation  
Friday Scientific Workshops

4:30 PM-4:40 PM

Friday Scientific Workshop on Hemoglobin Concentrations for Defining Anemia in Individuals and Populations


Conclusions and Study Needs  
Friday Scientific Workshops

4:35 PM-4:50 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Panel Discussion/Questions  
Friday Scientific Workshops

4:40 PM-4:45 PM

Friday Scientific Workshop on Hemoglobin Concentrations for Defining Anemia in Individuals and Populations


Closing Remarks  
Friday Scientific Workshops

4:50 PM-5:20 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda

5:00 PM-5:45 PM

Friday Scientific Workshop on Myeloid Development


Myeloid Malignancies  
Friday Scientific Workshops

5:00 PM-7:00 PM


Trainee Welcome Reception  
Trainee Activities and Services

5:05 PM-5:35 PM

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Panel Discussion  
Friday Scientific Workshops

5:05 PM-5:45 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

5:10 PM-5:55 PM

Friday Scientific Workshop on Inherited Hematopoietic Malignancies

5:20 PM-5:35 PM

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Panel Discussion/Questions  
Friday Scientific Workshops

5:35 PM-5:40 PM

Friday Scientific Workshop on Tumor Immune Interactions in Lymphoid Malignancies


Closing Remarks  
Friday Scientific Workshops

Friday Scientific Workshop on Hematology and Aging: Highlighting Novel Science and Promoting a Research Agenda


Closing Remarks  
Friday Scientific Workshops

5:45 PM-5:50 PM

Friday Scientific Workshop on Myeloid Development


Closing Remarks  
Friday Scientific Workshops

5:45 PM-5:55 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies

5:55 PM-6:00 PM

Friday Scientific Workshop on Integrative Clinical & Molecular Epidemiology of Hematologic Malignancies


Closing Remarks  
Friday Scientific Workshops

Friday Scientific Workshop on Inherited Hematopoietic Malignancies


Closing Remarks  
Friday Scientific Workshops

6:00 PM-10:00 PM

Saturday, December 9, 2017

7:00 AM-6:00 PM


Registration  
Events

7:30 AM-9:00 AM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Disorders of Platelet Number or Function

Disorders of Coagulation or Fibrinolysis

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myelodysplastic Syndromes—Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

9:00 AM-9:30 AM

9:00 AM-7:30 PM


Poster Viewing  
Events

9:30 AM-11:00 AM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Disorders of Coagulation or Fibrinolysis

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Myelodysplastic Syndromes—Basic and Translational Studies

Myeloma: Biology and Pathophysiology, excluding Therapy

Health Services Research—Non-Malignant Conditions


Novel Therapeutics in Myeloma  
Education Program


Targeting T-Cell Exhaustion  
Scientific Program

9:30 AM-11:30 AM

11:00 AM-12:30 PM

11:00 AM-5:00 PM


Exhibits Open  
Events

11:15 AM-12:15 PM


Aplastic Anemia  
How I Treat: Bringing Science to Clinical Dilemmas


ASH Grassroots Network Lunch  
Special-Interest Sessions

Career Development Lunch Sessions


Career Development Lunch Sessions: Room 1  
Trainee Activities and Services

Career Development Lunch Sessions


Career Development Lunch Sessions: Room 2  
Trainee Activities and Services


How Long to Anticoagulate My Patient With VTE  
How I Treat: Bringing Science to Clinical Dilemmas


Immune Thrombocytopenia  
How I Treat: Bringing Science to Clinical Dilemmas


Plasma Cells and Myeloma  
Meet the Scientist


Relapsed/Refractory Diffuse Large B-Cell Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Tailored Therapy for Patients With Hodgkin Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Thrombotic Thrombocytopenic Purpura  
How I Treat: Bringing Science to Clinical Dilemmas


Treating and Monitoring Patients With CML  
How I Treat: Bringing Science to Clinical Dilemmas

11:30 AM-12:30 PM

11:45 AM-12:45 PM

12:00 PM-1:30 PM

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Myelodysplastic Syndromes—Clinical Studies

Adoptive Immunotherapy

12:30 PM-1:30 PM


Ham-Wasserman Lecture  
General Sessions

1:30 PM-2:00 PM

2:00 PM-3:30 PM

Regulation of Iron Metabolism

Disorders of Coagulation or Fibrinolysis

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Myeloproliferative Syndromes: Clinical

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Health Services Research—Non-Malignant Conditions


Controversies in Myeloma  
Education Program


Special Symposium on Quality  
Special-Interest Sessions

3:30 PM-4:00 PM

4:00 PM-5:30 PM

Regulation of Iron Metabolism

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Outcomes Research—Malignant Conditions


Bone Marrow Failure: Acquired  
Education Program


Special Session on CAR T Therapy  
Special-Interest Sessions

5:30 PM-7:30 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism


102. Regulation of Iron Metabolism: Poster I  
Oral and Poster Abstracts

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis: Poster I  
Oral and Poster Abstracts

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster I  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster I  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster I  
Oral and Poster Abstracts

Cell Collection and Processing


711. Cell Collection and Processing: Poster I  
Oral and Poster Abstracts

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster I  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions

6:30 PM-8:00 PM

6:30 PM-9:00 PM

Sunday, December 10, 2017

7:00 AM-9:00 AM


Hematology Course Directors’ Workshop  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

7:30 AM-9:00 AM

Thalassemia and Globin Gene Regulation


112. Thalassemia and Globin Gene Regulation I  
Oral and Poster Abstracts

Disorders of Platelet Number or Function

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloma: Biology and Pathophysiology, excluding Therapy

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Health Services Research—Malignant Conditions

Outcomes Research—Malignant Conditions


ASH Foundation Run/Walk  
Special-Interest Sessions


Bone Marrow Failure: Inherited  
Education Program

9:00 AM-9:30 AM

9:00 AM-8:00 PM


Poster Viewing  
Events

9:30 AM-11:00 AM

Thalassemia and Globin Gene Regulation

Blood Coagulation and Fibrinolytic Factors

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Myeloproliferative Syndromes: Basic Science

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy

Clinical Autologous Transplantation: Results


Targeting T-Cell Exhaustion  
Scientific Program

9:30 AM-11:30 AM

10:00 AM-5:00 PM


Exhibits Open  
Events

11:00 AM-12:30 PM

11:15 AM-12:15 PM


ALL in Adolescents and Young Adults  
How I Treat: Bringing Science to Clinical Dilemmas


Heparin-Induced Thrombocytopenia: HITs and Misses  
How I Treat: Bringing Science to Clinical Dilemmas


Individualized Therapy in Patients With AML  
How I Treat: Bringing Science to Clinical Dilemmas


Meet the Blood Editors  
Special-Interest Sessions


Novel Therapy Combinations in Multiple Myeloma  
How I Treat: Bringing Science to Clinical Dilemmas


Platelet Clearance  
Meet the Scientist


Reversal of Anticoagulants  
How I Treat: Bringing Science to Clinical Dilemmas

Trainee Didactic Sessions


Trainee Didactic Session: Drug Development  
Trainee Activities and Services

Trainee Didactic Sessions


Trainee Didactic Session: Time Management and Balance  
Trainee Activities and Services

11:15 AM-12:30 PM


ASH Practice Partnership Lunch  
Special-Interest Sessions

11:30 AM-12:30 PM

12:00 PM-1:30 PM

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Therapy, excluding Transplantation

Myeloma: Therapy, excluding Transplantation

12:30 PM-1:30 PM


ASH-EHA Joint Symposium  
General Sessions

1:30 PM-2:00 PM

2:00 PM-4:00 PM

Plenary


Plenary Scientific Session  
General Sessions

4:00 PM-4:30 PM

4:30 PM-6:00 PM

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Granulocytes, Monocytes, and Macrophages

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis I  
Oral and Poster Abstracts

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Myeloproliferative Syndromes: Basic Science

CLL: Therapy, excluding Transplantation

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Health Services Research—Malignant Conditions


Blood and Beyond: The Art of Perception  
Special-Interest Sessions

4:30 PM-6:30 PM


Special Session on Systems-Based Hematology  
Special-Interest Sessions

6:00 PM-8:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism


102. Regulation of Iron Metabolism: Poster II  
Oral and Poster Abstracts

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis: Poster II  
Oral and Poster Abstracts

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster II  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster II  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster II  
Oral and Poster Abstracts

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster II  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions


Global Capacity-Building Showcase  
Global Capacity-Building Showcase


Global Capacity-Building Showcase (Display-Only Posters)  
Global Capacity-Building Showcase

Monday, December 11, 2017

7:00 AM-8:30 AM

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Granulocytes, Monocytes, and Macrophages

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis II  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Acute Myeloid Leukemia: Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Myelodysplastic Syndromes—Clinical Studies

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Health Services Research—Malignant Conditions

7:00 AM-11:30 AM


Consultative Hematology Course  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

9:00 AM-10:00 AM

10:00 AM-10:30 AM

10:00 AM-2:00 PM


Exhibits Open  
Events

10:00 AM-8:00 PM


Poster Viewing  
Events

10:30 AM-12:00 PM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Antithrombotic Therapy

Hematopoietic Stem and Progenitor Biology

Acute Myeloid Leukemia: Clinical Studies

Lymphoma Biology—Non-Genetic Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Results

Health Services Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions


Bone Marrow Failure: Inherited  
Education Program


Controversies in Myeloma  
Education Program

12:00 PM-1:30 PM

12:15 PM-1:15 PM


Global Hematology Symposium  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions

Trainee Didactic Sessions

Trainee Didactic Sessions

1:30 PM-2:30 PM

2:30 PM-2:45 PM

2:45 PM-4:15 PM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Lymphoma Biology—Non-Genetic Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Outcomes Research—Non-Malignant Conditions


Bone Marrow Failure: Acquired  
Education Program


Novel Therapeutics in Myeloma  
Education Program

4:30 PM-6:00 PM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Bone Marrow Failure


508. Bone Marrow Failure: Biology and Therapy  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

CLL: Therapy, excluding Transplantation

Myeloma: Therapy, excluding Transplantation

Adoptive Immunotherapy

Clinical Allogeneic Transplantation: Results

Chemical Biology and Experimental Therapeutics

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

4:30 PM-6:30 PM

6:00 PM-8:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster III  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster III  
Oral and Poster Abstracts

Cell Collection and Processing

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster III  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

6:15 PM-7:45 PM

Bone Marrow Failure

Oncogenes and Tumor Suppressors

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Chronic Myeloid Leukemia: Therapy

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Outcomes Research—Malignant Conditions

7:30 PM-9:00 PM


Networking Reception for Female Hematologists  
Special-Interest Sessions

Tuesday, December 12, 2017

7:00 AM-1:30 PM


Registration  
Events

7:30 AM-9:00 AM

Late-Breaking Abstracts


Late-Breaking Abstracts Session  
General Sessions

9:30 AM-9:45 AM

9:45 AM-11:15 AM


Presidential Symposium  
General Sessions

11:15 AM-11:30 AM


Business Meeting  
General Sessions

11:30 AM-1:00 PM


Best of ASH  
General Sessions